A Strategic Manufacturing Partner
for Complex Drug Products

About Emergent Bioservices

We are the contract development and manufacturing (CDMO) division of Emergent BioSolutions (NYSE: EBS). We have the scientific and regulatory compliance experience, development and manufacturing expertise, and efficient technology transfer capabilities that can harness the urgency, acuity, and scalability required to bring life-saving, life-extending products to market.

Our Commitment

Even when the world changes around us and new challenges emerge, our mission stays the same — to improve and protect the health of billions of people around the globe by supporting innovative drug makers that make the seemingly impossible possible. Read more about how our commitments to supporting regulatory and quality assurance excellence help our clients deliver their life-saving and life-extending products to market.

Customize Your Pathway

We understand that which approach fits you best can be found where science and business strategy intersect, where dynamics like speed, cost, and regulatory approach are balanced in precise harmony. And as a CDMO with the experience of an established biopharmaceutical company, Emergent stands ready to help reach your next clinical or commercial drug product milestone.

What We Do

Emergent Bioservices stands ready to put our resources, technology, and experience to work for you.


Development Services

Our clients have come to rely on Emergent for a broad range of development services, including process development for drug substance and drug product, and analytical development. Whether your program is in clinical or commercial phases, just starting up or scaling for growth, our development services are primed to plug in right where you need them.



Fill/Finish Services

Our drug product manufacturing capabilities are designed to support all phases of your product lifecycle. Whether you need small volumes of material for clinical research or large-scale manufacturing for a commercialized product, Emergent has the production, filling, and packaging expertise to support your growth and scale-up, now and in the future.


 ico-mic-carmine In the News

Outsourced Pharma Capacity Update | July 2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live...

Read More

Case Study Corner: Streamlining R&D to Manufacturing

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible possible. In our latest blog series, Case Study Corner, discover how we've helped our clients overcome their biggest...

Read More

A Strategic and Collaborative Partner 

Global health risks. Rare disease therapeutics. Novel medicines.  No matter where your innovation is centered, you'll find us a like-minded and more-than-capable partner. And, no matter where we begin with your project, we maintain a holistic perspective as we help you accelerate along your process development and manufacturing pathway.

Tox Lots, Demo Batches
Process Development
Analytical Development, Phase Appropriate Validation, Stability
Tech Transfer, Scale Up
Process Characterization, Characterization Testing
Clinical & Commercial Drug Product Manufacturing
Packaging & Labeling, Cold Storage
Stability, Lot Release Testing
Dedicated Project Management
Regulatory & Inspection Support

The Power of the
Emergent Way

“The Emergent Way” is visible in everything we do for you. The elements that define it aren’t labeled that way, of course, but you’ll see the hallmarks of what make us different at every turn.

Flexible & Scalable Technologies
Efficient Tech Transfer
Agility and Reliability
Passion for the Vision
Partnership Thinking
Entrepreneurial Spirit

Let’s Start A Conversation

Connect now